Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q1 2024 call → NOWe need to determine if management conveys that the company is small relative to the scale of current business arriving. Look for statements about disproportionate growth, small base, large opportunities relative to size. In the transcript, Kevin Neveu discusses Canada: "we have 48 rigs operating compared to 38 this time last year. 9 of the 10 rig increase are Super Singles targeting heavy oil. We see this momentum continuing throughout the summer and exceeding our prior view on Canadian rig demand." Also mentions "several customers are seeking to upgrade additional Super Singles to Pad our rigs. These $2 million to $3 million upgrades come with market-leading day rates and long-term take-or-pay contracts." Also "we may have the opportunity to mobilize additional capacity from the U.S. back to Canada early next year." Also "we expect to trend to the mid-60s by the end of June and into the 70s in July, well ahead of last year’s pace." This indicates strong growth but does it convey disproportion relative to company size? The company is a large drilling contractor. They have many rigs. The growth is significant but not necessarily "small company" disproportion. They are a leading participant. The question asks: "the company is small, and what is happening to it now is disproportionately large compared with that smallness." Precision Drilling is a major player. They have 38 rigs in US, 73 in Canada, etc. They are not small. The growth is strong but not disproportionate relative to their size. They are already a leading participant. So answer NO. Check for any explicit statement about being small or outsized. No such language. They talk about "exceeding our prior view" but that's normal growth. No mention of small base. So NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.